Global Artificial Cardiopulmonary Machine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Artificial Cardiopulmonary Machine Industry Forecast” looks at past sales and reviews total world Artificial Cardiopulmonary Machine sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Cardiopulmonary Machine sales for 2023 through 2029. With Artificial Cardiopulmonary Machine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Cardiopulmonary Machine industry.
This Insight Report provides a comprehensive analysis of the global Artificial Cardiopulmonary Machine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Cardiopulmonary Machine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Cardiopulmonary Machine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Cardiopulmonary Machine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Cardiopulmonary Machine.
The global Artificial Cardiopulmonary Machine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artificial Cardiopulmonary Machine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Cardiopulmonary Machine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Cardiopulmonary Machine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Cardiopulmonary Machine players cover LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica and Tianjin Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cardiopulmonary Machine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Artificial Cardiopulmonary Machine market?
What factors are driving Artificial Cardiopulmonary Machine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Cardiopulmonary Machine market opportunities vary by end market size?
How does Artificial Cardiopulmonary Machine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Artificial Cardiopulmonary Machine Industry Forecast” looks at past sales and reviews total world Artificial Cardiopulmonary Machine sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Cardiopulmonary Machine sales for 2023 through 2029. With Artificial Cardiopulmonary Machine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Cardiopulmonary Machine industry.
This Insight Report provides a comprehensive analysis of the global Artificial Cardiopulmonary Machine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Cardiopulmonary Machine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Cardiopulmonary Machine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Cardiopulmonary Machine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Cardiopulmonary Machine.
The global Artificial Cardiopulmonary Machine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artificial Cardiopulmonary Machine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Cardiopulmonary Machine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Cardiopulmonary Machine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Cardiopulmonary Machine players cover LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica and Tianjin Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cardiopulmonary Machine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Single Roller Pump HLM
- Double Roller Pump HLM
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Tianjin Medical
What is the 10-year outlook for the global Artificial Cardiopulmonary Machine market?
What factors are driving Artificial Cardiopulmonary Machine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Cardiopulmonary Machine market opportunities vary by end market size?
How does Artificial Cardiopulmonary Machine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Cardiopulmonary Machine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Artificial Cardiopulmonary Machine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Artificial Cardiopulmonary Machine by Country/Region, 2018, 2022 & 2029
2.2 Artificial Cardiopulmonary Machine Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.3 Artificial Cardiopulmonary Machine Sales by Type
2.3.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
2.3.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Artificial Cardiopulmonary Machine Sale Price by Type (2018-2023)
2.4 Artificial Cardiopulmonary Machine Segment by Application
2.4.1 Cardiac Surgery
2.4.2 Lung Transplant Operation
2.4.3 Acute Respiratory Failure Treatment
2.4.4 Others
2.5 Artificial Cardiopulmonary Machine Sales by Application
2.5.1 Global Artificial Cardiopulmonary Machine Sale Market Share by Application (2018-2023)
2.5.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Artificial Cardiopulmonary Machine Sale Price by Application (2018-2023)
3 GLOBAL ARTIFICIAL CARDIOPULMONARY MACHINE BY COMPANY
3.1 Global Artificial Cardiopulmonary Machine Breakdown Data by Company
3.1.1 Global Artificial Cardiopulmonary Machine Annual Sales by Company (2018-2023)
3.1.2 Global Artificial Cardiopulmonary Machine Sales Market Share by Company (2018-2023)
3.2 Global Artificial Cardiopulmonary Machine Annual Revenue by Company (2018-2023)
3.2.1 Global Artificial Cardiopulmonary Machine Revenue by Company (2018-2023)
3.2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Company (2018-2023)
3.3 Global Artificial Cardiopulmonary Machine Sale Price by Company
3.4 Key Manufacturers Artificial Cardiopulmonary Machine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Cardiopulmonary Machine Product Location Distribution
3.4.2 Players Artificial Cardiopulmonary Machine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL CARDIOPULMONARY MACHINE BY GEOGRAPHIC REGION
4.1 World Historic Artificial Cardiopulmonary Machine Market Size by Geographic Region (2018-2023)
4.1.1 Global Artificial Cardiopulmonary Machine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Artificial Cardiopulmonary Machine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Artificial Cardiopulmonary Machine Market Size by Country/Region (2018-2023)
4.2.1 Global Artificial Cardiopulmonary Machine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Artificial Cardiopulmonary Machine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Artificial Cardiopulmonary Machine Sales Growth
4.4 APAC Artificial Cardiopulmonary Machine Sales Growth
4.5 Europe Artificial Cardiopulmonary Machine Sales Growth
4.6 Middle East & Africa Artificial Cardiopulmonary Machine Sales Growth
5 AMERICAS
5.1 Americas Artificial Cardiopulmonary Machine Sales by Country
5.1.1 Americas Artificial Cardiopulmonary Machine Sales by Country (2018-2023)
5.1.2 Americas Artificial Cardiopulmonary Machine Revenue by Country (2018-2023)
5.2 Americas Artificial Cardiopulmonary Machine Sales by Type
5.3 Americas Artificial Cardiopulmonary Machine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Cardiopulmonary Machine Sales by Region
6.1.1 APAC Artificial Cardiopulmonary Machine Sales by Region (2018-2023)
6.1.2 APAC Artificial Cardiopulmonary Machine Revenue by Region (2018-2023)
6.2 APAC Artificial Cardiopulmonary Machine Sales by Type
6.3 APAC Artificial Cardiopulmonary Machine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Cardiopulmonary Machine by Country
7.1.1 Europe Artificial Cardiopulmonary Machine Sales by Country (2018-2023)
7.1.2 Europe Artificial Cardiopulmonary Machine Revenue by Country (2018-2023)
7.2 Europe Artificial Cardiopulmonary Machine Sales by Type
7.3 Europe Artificial Cardiopulmonary Machine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Cardiopulmonary Machine by Country
8.1.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2018-2023)
8.2 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type
8.3 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Cardiopulmonary Machine
10.3 Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
10.4 Industry Chain Structure of Artificial Cardiopulmonary Machine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Cardiopulmonary Machine Distributors
11.3 Artificial Cardiopulmonary Machine Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL CARDIOPULMONARY MACHINE BY GEOGRAPHIC REGION
12.1 Global Artificial Cardiopulmonary Machine Market Size Forecast by Region
12.1.1 Global Artificial Cardiopulmonary Machine Forecast by Region (2024-2029)
12.1.2 Global Artificial Cardiopulmonary Machine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artificial Cardiopulmonary Machine Forecast by Type
12.7 Global Artificial Cardiopulmonary Machine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 LivaNova (Sorin)
13.1.1 LivaNova (Sorin) Company Information
13.1.2 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 LivaNova (Sorin) Main Business Overview
13.1.5 LivaNova (Sorin) Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo CV Group
13.4.1 Terumo CV Group Company Information
13.4.2 Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Terumo CV Group Main Business Overview
13.4.5 Terumo CV Group Latest Developments
13.5 Braile Biomedica
13.5.1 Braile Biomedica Company Information
13.5.2 Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Braile Biomedica Main Business Overview
13.5.5 Braile Biomedica Latest Developments
13.6 Tianjin Medical
13.6.1 Tianjin Medical Company Information
13.6.2 Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tianjin Medical Main Business Overview
13.6.5 Tianjin Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Cardiopulmonary Machine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Artificial Cardiopulmonary Machine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Artificial Cardiopulmonary Machine by Country/Region, 2018, 2022 & 2029
2.2 Artificial Cardiopulmonary Machine Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.3 Artificial Cardiopulmonary Machine Sales by Type
2.3.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
2.3.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Artificial Cardiopulmonary Machine Sale Price by Type (2018-2023)
2.4 Artificial Cardiopulmonary Machine Segment by Application
2.4.1 Cardiac Surgery
2.4.2 Lung Transplant Operation
2.4.3 Acute Respiratory Failure Treatment
2.4.4 Others
2.5 Artificial Cardiopulmonary Machine Sales by Application
2.5.1 Global Artificial Cardiopulmonary Machine Sale Market Share by Application (2018-2023)
2.5.2 Global Artificial Cardiopulmonary Machine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Artificial Cardiopulmonary Machine Sale Price by Application (2018-2023)
3 GLOBAL ARTIFICIAL CARDIOPULMONARY MACHINE BY COMPANY
3.1 Global Artificial Cardiopulmonary Machine Breakdown Data by Company
3.1.1 Global Artificial Cardiopulmonary Machine Annual Sales by Company (2018-2023)
3.1.2 Global Artificial Cardiopulmonary Machine Sales Market Share by Company (2018-2023)
3.2 Global Artificial Cardiopulmonary Machine Annual Revenue by Company (2018-2023)
3.2.1 Global Artificial Cardiopulmonary Machine Revenue by Company (2018-2023)
3.2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Company (2018-2023)
3.3 Global Artificial Cardiopulmonary Machine Sale Price by Company
3.4 Key Manufacturers Artificial Cardiopulmonary Machine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Cardiopulmonary Machine Product Location Distribution
3.4.2 Players Artificial Cardiopulmonary Machine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL CARDIOPULMONARY MACHINE BY GEOGRAPHIC REGION
4.1 World Historic Artificial Cardiopulmonary Machine Market Size by Geographic Region (2018-2023)
4.1.1 Global Artificial Cardiopulmonary Machine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Artificial Cardiopulmonary Machine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Artificial Cardiopulmonary Machine Market Size by Country/Region (2018-2023)
4.2.1 Global Artificial Cardiopulmonary Machine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Artificial Cardiopulmonary Machine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Artificial Cardiopulmonary Machine Sales Growth
4.4 APAC Artificial Cardiopulmonary Machine Sales Growth
4.5 Europe Artificial Cardiopulmonary Machine Sales Growth
4.6 Middle East & Africa Artificial Cardiopulmonary Machine Sales Growth
5 AMERICAS
5.1 Americas Artificial Cardiopulmonary Machine Sales by Country
5.1.1 Americas Artificial Cardiopulmonary Machine Sales by Country (2018-2023)
5.1.2 Americas Artificial Cardiopulmonary Machine Revenue by Country (2018-2023)
5.2 Americas Artificial Cardiopulmonary Machine Sales by Type
5.3 Americas Artificial Cardiopulmonary Machine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Cardiopulmonary Machine Sales by Region
6.1.1 APAC Artificial Cardiopulmonary Machine Sales by Region (2018-2023)
6.1.2 APAC Artificial Cardiopulmonary Machine Revenue by Region (2018-2023)
6.2 APAC Artificial Cardiopulmonary Machine Sales by Type
6.3 APAC Artificial Cardiopulmonary Machine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Cardiopulmonary Machine by Country
7.1.1 Europe Artificial Cardiopulmonary Machine Sales by Country (2018-2023)
7.1.2 Europe Artificial Cardiopulmonary Machine Revenue by Country (2018-2023)
7.2 Europe Artificial Cardiopulmonary Machine Sales by Type
7.3 Europe Artificial Cardiopulmonary Machine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Cardiopulmonary Machine by Country
8.1.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2018-2023)
8.2 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type
8.3 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Cardiopulmonary Machine
10.3 Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
10.4 Industry Chain Structure of Artificial Cardiopulmonary Machine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Cardiopulmonary Machine Distributors
11.3 Artificial Cardiopulmonary Machine Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL CARDIOPULMONARY MACHINE BY GEOGRAPHIC REGION
12.1 Global Artificial Cardiopulmonary Machine Market Size Forecast by Region
12.1.1 Global Artificial Cardiopulmonary Machine Forecast by Region (2024-2029)
12.1.2 Global Artificial Cardiopulmonary Machine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artificial Cardiopulmonary Machine Forecast by Type
12.7 Global Artificial Cardiopulmonary Machine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 LivaNova (Sorin)
13.1.1 LivaNova (Sorin) Company Information
13.1.2 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 LivaNova (Sorin) Main Business Overview
13.1.5 LivaNova (Sorin) Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo CV Group
13.4.1 Terumo CV Group Company Information
13.4.2 Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Terumo CV Group Main Business Overview
13.4.5 Terumo CV Group Latest Developments
13.5 Braile Biomedica
13.5.1 Braile Biomedica Company Information
13.5.2 Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Braile Biomedica Main Business Overview
13.5.5 Braile Biomedica Latest Developments
13.6 Tianjin Medical
13.6.1 Tianjin Medical Company Information
13.6.2 Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolios and Specifications
13.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Tianjin Medical Main Business Overview
13.6.5 Tianjin Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Cardiopulmonary Machine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Artificial Cardiopulmonary Machine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Roller Pump HLM
Table 4. Major Players of Double Roller Pump HLM
Table 5. Global Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 6. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Table 7. Global Artificial Cardiopulmonary Machine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2018-2023)
Table 9. Global Artificial Cardiopulmonary Machine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 11. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Table 12. Global Artificial Cardiopulmonary Machine Revenue by Application (2018-2023)
Table 13. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2018-2023)
Table 14. Global Artificial Cardiopulmonary Machine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Artificial Cardiopulmonary Machine Sales by Company (2018-2023) & (K Units)
Table 16. Global Artificial Cardiopulmonary Machine Sales Market Share by Company (2018-2023)
Table 17. Global Artificial Cardiopulmonary Machine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company (2018-2023)
Table 19. Global Artificial Cardiopulmonary Machine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Artificial Cardiopulmonary Machine Producing Area Distribution and Sales Area
Table 21. Players Artificial Cardiopulmonary Machine Products Offered
Table 22. Artificial Cardiopulmonary Machine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Artificial Cardiopulmonary Machine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Artificial Cardiopulmonary Machine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Artificial Cardiopulmonary Machine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Artificial Cardiopulmonary Machine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Artificial Cardiopulmonary Machine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Artificial Cardiopulmonary Machine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Artificial Cardiopulmonary Machine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Artificial Cardiopulmonary Machine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2023)
Table 35. Americas Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2023)
Table 37. Americas Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Artificial Cardiopulmonary Machine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Artificial Cardiopulmonary Machine Sales Market Share by Region (2018-2023)
Table 41. APAC Artificial Cardiopulmonary Machine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Artificial Cardiopulmonary Machine Revenue Market Share by Region (2018-2023)
Table 43. APAC Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2023)
Table 47. Europe Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2023)
Table 49. Europe Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Artificial Cardiopulmonary Machine
Table 58. Key Market Challenges & Risks of Artificial Cardiopulmonary Machine
Table 59. Key Industry Trends of Artificial Cardiopulmonary Machine
Table 60. Artificial Cardiopulmonary Machine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Artificial Cardiopulmonary Machine Distributors List
Table 63. Artificial Cardiopulmonary Machine Customer List
Table 64. Global Artificial Cardiopulmonary Machine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Artificial Cardiopulmonary Machine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Artificial Cardiopulmonary Machine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Artificial Cardiopulmonary Machine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Artificial Cardiopulmonary Machine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Artificial Cardiopulmonary Machine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Artificial Cardiopulmonary Machine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Artificial Cardiopulmonary Machine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Artificial Cardiopulmonary Machine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Artificial Cardiopulmonary Machine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Artificial Cardiopulmonary Machine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Artificial Cardiopulmonary Machine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Artificial Cardiopulmonary Machine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. LivaNova (Sorin) Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 79. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 80. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. LivaNova (Sorin) Main Business
Table 82. LivaNova (Sorin) Latest Developments
Table 83. Getinge (Maquet) Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 84. Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 85. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Getinge (Maquet) Main Business
Table 87. Getinge (Maquet) Latest Developments
Table 88. Medtronic Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 90. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Terumo CV Group Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 94. Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 95. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Terumo CV Group Main Business
Table 97. Terumo CV Group Latest Developments
Table 98. Braile Biomedica Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 99. Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 100. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Braile Biomedica Main Business
Table 102. Braile Biomedica Latest Developments
Table 103. Tianjin Medical Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 104. Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 105. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Tianjin Medical Main Business
Table 107. Tianjin Medical Latest Developments
Table 1. Artificial Cardiopulmonary Machine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Artificial Cardiopulmonary Machine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Roller Pump HLM
Table 4. Major Players of Double Roller Pump HLM
Table 5. Global Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 6. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Table 7. Global Artificial Cardiopulmonary Machine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2018-2023)
Table 9. Global Artificial Cardiopulmonary Machine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 11. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Table 12. Global Artificial Cardiopulmonary Machine Revenue by Application (2018-2023)
Table 13. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2018-2023)
Table 14. Global Artificial Cardiopulmonary Machine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Artificial Cardiopulmonary Machine Sales by Company (2018-2023) & (K Units)
Table 16. Global Artificial Cardiopulmonary Machine Sales Market Share by Company (2018-2023)
Table 17. Global Artificial Cardiopulmonary Machine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company (2018-2023)
Table 19. Global Artificial Cardiopulmonary Machine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Artificial Cardiopulmonary Machine Producing Area Distribution and Sales Area
Table 21. Players Artificial Cardiopulmonary Machine Products Offered
Table 22. Artificial Cardiopulmonary Machine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Artificial Cardiopulmonary Machine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Artificial Cardiopulmonary Machine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Artificial Cardiopulmonary Machine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Artificial Cardiopulmonary Machine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Artificial Cardiopulmonary Machine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Artificial Cardiopulmonary Machine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Artificial Cardiopulmonary Machine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Artificial Cardiopulmonary Machine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2023)
Table 35. Americas Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2023)
Table 37. Americas Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Artificial Cardiopulmonary Machine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Artificial Cardiopulmonary Machine Sales Market Share by Region (2018-2023)
Table 41. APAC Artificial Cardiopulmonary Machine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Artificial Cardiopulmonary Machine Revenue Market Share by Region (2018-2023)
Table 43. APAC Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2023)
Table 47. Europe Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2023)
Table 49. Europe Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Artificial Cardiopulmonary Machine
Table 58. Key Market Challenges & Risks of Artificial Cardiopulmonary Machine
Table 59. Key Industry Trends of Artificial Cardiopulmonary Machine
Table 60. Artificial Cardiopulmonary Machine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Artificial Cardiopulmonary Machine Distributors List
Table 63. Artificial Cardiopulmonary Machine Customer List
Table 64. Global Artificial Cardiopulmonary Machine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Artificial Cardiopulmonary Machine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Artificial Cardiopulmonary Machine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Artificial Cardiopulmonary Machine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Artificial Cardiopulmonary Machine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Artificial Cardiopulmonary Machine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Artificial Cardiopulmonary Machine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Artificial Cardiopulmonary Machine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Artificial Cardiopulmonary Machine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Artificial Cardiopulmonary Machine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Artificial Cardiopulmonary Machine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Artificial Cardiopulmonary Machine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Artificial Cardiopulmonary Machine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. LivaNova (Sorin) Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 79. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 80. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. LivaNova (Sorin) Main Business
Table 82. LivaNova (Sorin) Latest Developments
Table 83. Getinge (Maquet) Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 84. Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 85. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Getinge (Maquet) Main Business
Table 87. Getinge (Maquet) Latest Developments
Table 88. Medtronic Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 90. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Terumo CV Group Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 94. Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 95. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Terumo CV Group Main Business
Table 97. Terumo CV Group Latest Developments
Table 98. Braile Biomedica Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 99. Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 100. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Braile Biomedica Main Business
Table 102. Braile Biomedica Latest Developments
Table 103. Tianjin Medical Basic Information, Artificial Cardiopulmonary Machine Manufacturing Base, Sales Area and Its Competitors
Table 104. Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolios and Specifications
Table 105. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Tianjin Medical Main Business
Table 107. Tianjin Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artificial Cardiopulmonary Machine
Figure 2. Artificial Cardiopulmonary Machine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Cardiopulmonary Machine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Artificial Cardiopulmonary Machine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Artificial Cardiopulmonary Machine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Roller Pump HLM
Figure 10. Product Picture of Double Roller Pump HLM
Figure 11. Global Artificial Cardiopulmonary Machine Sales Market Share by Type in 2022
Figure 12. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2018-2023)
Figure 13. Artificial Cardiopulmonary Machine Consumed in Cardiac Surgery
Figure 14. Global Artificial Cardiopulmonary Machine Market: Cardiac Surgery (2018-2023) & (K Units)
Figure 15. Artificial Cardiopulmonary Machine Consumed in Lung Transplant Operation
Figure 16. Global Artificial Cardiopulmonary Machine Market: Lung Transplant Operation (2018-2023) & (K Units)
Figure 17. Artificial Cardiopulmonary Machine Consumed in Acute Respiratory Failure Treatment
Figure 18. Global Artificial Cardiopulmonary Machine Market: Acute Respiratory Failure Treatment (2018-2023) & (K Units)
Figure 19. Artificial Cardiopulmonary Machine Consumed in Others
Figure 20. Global Artificial Cardiopulmonary Machine Market: Others (2018-2023) & (K Units)
Figure 21. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2022)
Figure 22. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application in 2022
Figure 23. Artificial Cardiopulmonary Machine Sales Market by Company in 2022 (K Units)
Figure 24. Global Artificial Cardiopulmonary Machine Sales Market Share by Company in 2022
Figure 25. Artificial Cardiopulmonary Machine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company in 2022
Figure 27. Global Artificial Cardiopulmonary Machine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Artificial Cardiopulmonary Machine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 30. Americas Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 32. APAC Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 34. Europe Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Artificial Cardiopulmonary Machine Sales Market Share by Country in 2022
Figure 38. Americas Artificial Cardiopulmonary Machine Revenue Market Share by Country in 2022
Figure 39. Americas Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 40. Americas Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 41. United States Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Artificial Cardiopulmonary Machine Sales Market Share by Region in 2022
Figure 46. APAC Artificial Cardiopulmonary Machine Revenue Market Share by Regions in 2022
Figure 47. APAC Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 48. APAC Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 49. China Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country in 2022
Figure 57. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country in 2022
Figure 58. Europe Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 59. Europe Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 60. Germany Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Artificial Cardiopulmonary Machine in 2022
Figure 75. Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
Figure 76. Industry Chain Structure of Artificial Cardiopulmonary Machine
Figure 77. Channels of Distribution
Figure 78. Global Artificial Cardiopulmonary Machine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Artificial Cardiopulmonary Machine
Figure 2. Artificial Cardiopulmonary Machine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Cardiopulmonary Machine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Artificial Cardiopulmonary Machine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Artificial Cardiopulmonary Machine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Roller Pump HLM
Figure 10. Product Picture of Double Roller Pump HLM
Figure 11. Global Artificial Cardiopulmonary Machine Sales Market Share by Type in 2022
Figure 12. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2018-2023)
Figure 13. Artificial Cardiopulmonary Machine Consumed in Cardiac Surgery
Figure 14. Global Artificial Cardiopulmonary Machine Market: Cardiac Surgery (2018-2023) & (K Units)
Figure 15. Artificial Cardiopulmonary Machine Consumed in Lung Transplant Operation
Figure 16. Global Artificial Cardiopulmonary Machine Market: Lung Transplant Operation (2018-2023) & (K Units)
Figure 17. Artificial Cardiopulmonary Machine Consumed in Acute Respiratory Failure Treatment
Figure 18. Global Artificial Cardiopulmonary Machine Market: Acute Respiratory Failure Treatment (2018-2023) & (K Units)
Figure 19. Artificial Cardiopulmonary Machine Consumed in Others
Figure 20. Global Artificial Cardiopulmonary Machine Market: Others (2018-2023) & (K Units)
Figure 21. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2022)
Figure 22. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application in 2022
Figure 23. Artificial Cardiopulmonary Machine Sales Market by Company in 2022 (K Units)
Figure 24. Global Artificial Cardiopulmonary Machine Sales Market Share by Company in 2022
Figure 25. Artificial Cardiopulmonary Machine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Artificial Cardiopulmonary Machine Revenue Market Share by Company in 2022
Figure 27. Global Artificial Cardiopulmonary Machine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Artificial Cardiopulmonary Machine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 30. Americas Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 32. APAC Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 34. Europe Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Artificial Cardiopulmonary Machine Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Artificial Cardiopulmonary Machine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Artificial Cardiopulmonary Machine Sales Market Share by Country in 2022
Figure 38. Americas Artificial Cardiopulmonary Machine Revenue Market Share by Country in 2022
Figure 39. Americas Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 40. Americas Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 41. United States Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Artificial Cardiopulmonary Machine Sales Market Share by Region in 2022
Figure 46. APAC Artificial Cardiopulmonary Machine Revenue Market Share by Regions in 2022
Figure 47. APAC Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 48. APAC Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 49. China Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country in 2022
Figure 57. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country in 2022
Figure 58. Europe Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 59. Europe Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 60. Germany Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Artificial Cardiopulmonary Machine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Artificial Cardiopulmonary Machine in 2022
Figure 75. Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
Figure 76. Industry Chain Structure of Artificial Cardiopulmonary Machine
Figure 77. Channels of Distribution
Figure 78. Global Artificial Cardiopulmonary Machine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Application (2024-2029)
